News

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...
Biosimilars offer high-quality, lower-cost cancer treatments. Learn how they’re helping patients and reshaping global ...
A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin ...
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
Innovent Biologics doses first participant in phase 3 clinical study of picankibart: San Francisco Friday, May 30, 2025, 12:00 Hrs [IST] Innovent Biologics, Inc, a world-class bio ...
Patients who begin biologic treatment for severe asthma have fewer new-onset adverse outcomes than those who do not begin biologics, according to a poster presented at the American Thoracic Society ...
At a time when the mental health crisis in America is pushing clinicians and researchers to rethink traditional trauma care ...